Benitec Biopharma Financial Overview
Benitec Biopharma's market cap is currently $420.23M. The company's EPS TTM is $-0.22; its P/E ratio is -10.73; Benitec Biopharma is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
